Exhibit 1 JOINT FILING AGREEMENT In accordance with Rule 13d-1(k) (1) (iii) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13G filed on...Joint Filing Agreement • December 19th, 2003 • Smithfield Fiduciary LLC • Pharmaceutical preparations
In accordance with Rule 13d-1(k) (1) (iii) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13G filed on December 19, 2003 (including amendments thereto) with respect to the common stock of Guilford Pharmaceuticals Inc.
EXHIBIT I JOINT FILING AGREEMENT This will confirm the agreement by and among the undersigned that the Schedule 13G/A filed with the Securities and Exchange Commission on or about the date hereof with respect to the beneficial ownership by the...Joint Filing Agreement • February 14th, 2005 • Smithfield Fiduciary LLC • In vitro & in vivo diagnostic substances
This will confirm the agreement by and among the undersigned that the Schedule 13G/A filed with the Securities and Exchange Commission on or about the date hereof with respect to the beneficial ownership by the undersigned of the Class "A" Ordinary Shares of Trinity Biotech plc is being filed, and all amendments thereto will be filed, on behalf of each of the persons and entities named below in accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.
Exhibit Index ------------- Exhibit Description ------- ----------- 1 Joint Filing AgreementJoint Filing Agreement • March 8th, 2004 • Smithfield Fiduciary LLC • In vitro & in vivo diagnostic substances
In accordance with Rule 13d-1(k) (1) (iii) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13G/A dated March 8, 2004 (including amendments thereto) with respect to the Class "A" Ordinary Shares of Trinity Biotech plc.
